ALLIANCES AND MERGERS BETWEEN SMEs TODAY MAKES SENSE, especially in the Biopharma sector. VCs have withdrawn, and Big Pharma is bearing the weight of solicitations, but is overwhelmed and the response times have become ridiculous. Most companies looking for collaborations and capital have failed to explore the layers of smaller companies below the giants. Many have capital, many are active in BD, and are interested in product licenses and filling their pipelines. In this economic climate, it is inevitable that market efficiencies will lead to combined similar programs.
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022